Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-016908
Filing Date
2022-05-05
Accepted
2022-05-05 18:30:35
Documents
1
Period of Report
2022-05-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2489
  Complete submission text file 0000899243-22-016908.txt   4408
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Reporting) CIK: 0000885590 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-41380 | Film No.: 22898200
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 BC V6B 0M3
Business Address 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 BC V6B 0M3 908-541-5456
Bausch & Lomb Corp (Issuer) CIK: 0001860742 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 3851 Ophthalmic Goods